EUVIMEDEUVIMED entdecken
Crossref

Loss of CD20 Expression after Rituximab Therapy for B-Cell Lymphomas: A Review of the Literature

Naoki Wada, Katsuyuki Aozasa

Cancer and Clinical Oncology · 2012

DOI: 10.5539/cco.v1n2p1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer and Clinical Oncology, 2012. Verfasst von Naoki Wada und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wada, N., & Aozasa, K. (2012). Loss of CD20 Expression after Rituximab Therapy for B-Cell Lymphomas: A Review of the Literature. Cancer and Clinical Oncology. https://doi.org/10.5539/cco.v1n2p1

Vancouver

Wada N, Aozasa K. Loss of CD20 Expression after Rituximab Therapy for B-Cell Lymphomas: A Review of the Literature. Cancer and Clinical Oncology. 2012. doi:10.5539/cco.v1n2p1

BibTeX
@article{Wada2012,
  author = {Wada, Naoki and Aozasa, Katsuyuki},
  title = {Loss of CD20 Expression after Rituximab Therapy for B-Cell Lymphomas: A Review of the Literature},
  journal = {Cancer and Clinical Oncology},
  year = {2012},
  doi = {10.5539/cco.v1n2p1}
}
Kostenlos starten →